Neurocrine Biosciences (NBIX) OCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | 256.5 | 339.4 | 389.9 | 595.4 | 782.7 | 863.7 | ||
| Changes by years, y/y, % | +12% | +32% | +15% | +53% | +31% | +27.9% | |||
Neurocrine Biosciences. OCF, bln rub
Neurocrine Biosciences. OCF, changes, %
Neurocrine Biosciences. OCF, sum by quarters, bln rub
Neurocrine Biosciences (NBIX) OCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| OCF, bln rub | ? | 64.8 | 102.0 | 227.5 | 388.4 | 145.8 | 863.7 | |
| Changes by years, y/y, % | -50% | +58% | +44% | +60% | +125% | |||
| Changes by quarters, q/q, % | -73% | +57% | +123% | +71% | -62% | |||